# Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis

> **NCT06307314** · — · RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 300 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma
- Head and Neck Cancer
- Radiotherapy-induced Oral Mucositis
- Biomarker

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06307314
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06307314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06307314, "Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06307314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*